Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1190561016 | Pyrimethamine+dapsone 12.5mg/100mg tablet (product) | en | Fully specified name | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 3470803016 | Product containing pyrimethamine 12.5 mg and dapsone 100 mg/1 each oral tablet | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3489312014 | Product containing pyrimethamine 12.5 mg and dapsone 100 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3500758012 | Pyrimethamine 12.5 mg and dapsone 100 mg oral tablet | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3566702015 | Product containing only pyrimethamine 12.5 mg and dapsone 100 mg/1 each oral tablet | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3566703013 | Product containing only pyrimethamine 12.5 mg and dapsone 100 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3682460018 | Product containing precisely dapsone 100 milligram and pyrimethamine 12.5 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3682461019 | Dapsone 100 mg and pyrimethamine 12.5 mg oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3682462014 | Product containing precisely dapsone 100 milligram and pyrimethamine 12.5 milligram/1 each conventional release oral tablet | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 465614011 | Pyrimethamine+dapsone 12.5mg/100mg tablet | en | Synonym (core metadata concept) | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 718193014 | Pyrimethamine+dapsone 12.5mg/100mg tablet (substance) | en | Fully specified name | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely dapsone 100 milligram and pyrimethamine 12.5 milligram/1 each conventional release oral tablet (clinical drug) | est un(e) (attribut) | Dapsone and pyrimethamine only product in oral dose form | true | Inferred relationship | Some | ||
| Product containing precisely dapsone 100 milligram and pyrimethamine 12.5 milligram/1 each conventional release oral tablet (clinical drug) | Plays role | Antileprotic therapeutic role | true | Inferred relationship | Some | ||
| Product containing precisely dapsone 100 milligram and pyrimethamine 12.5 milligram/1 each conventional release oral tablet (clinical drug) | Plays role | Antimalarial therapeutic role | true | Inferred relationship | Some | ||
| Product containing precisely dapsone 100 milligram and pyrimethamine 12.5 milligram/1 each conventional release oral tablet (clinical drug) | est un(e) (attribut) | Product containing pyrimethamine (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely dapsone 100 milligram and pyrimethamine 12.5 milligram/1 each conventional release oral tablet (clinical drug) | est un(e) (attribut) | dapsone | false | Inferred relationship | Some | ||
| Product containing precisely dapsone 100 milligram and pyrimethamine 12.5 milligram/1 each conventional release oral tablet (clinical drug) | a pour principe actif (attribut) | Pyrimethamine (substance) | false | Inferred relationship | Some | ||
| Product containing precisely dapsone 100 milligram and pyrimethamine 12.5 milligram/1 each conventional release oral tablet (clinical drug) | a pour principe actif (attribut) | Dapsone (substance) | false | Inferred relationship | Some | ||
| Product containing precisely dapsone 100 milligram and pyrimethamine 12.5 milligram/1 each conventional release oral tablet (clinical drug) | est un(e) (attribut) | Product containing dapsone and pyrimethamine (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely dapsone 100 milligram and pyrimethamine 12.5 milligram/1 each conventional release oral tablet (clinical drug) | a une forme pharmaceutique (attribut) | comprimé | false | Inferred relationship | Some | ||
| Product containing precisely dapsone 100 milligram and pyrimethamine 12.5 milligram/1 each conventional release oral tablet (clinical drug) | a pour principe actif (attribut) | Bactericide | false | Inferred relationship | Some | ||
| Product containing precisely dapsone 100 milligram and pyrimethamine 12.5 milligram/1 each conventional release oral tablet (clinical drug) | a une forme pharmaceutique (attribut) | Oral tablet | true | Inferred relationship | Some | ||
| Product containing precisely dapsone 100 milligram and pyrimethamine 12.5 milligram/1 each conventional release oral tablet (clinical drug) | est un(e) (attribut) | Product containing dapsone in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Product containing precisely dapsone 100 milligram and pyrimethamine 12.5 milligram/1 each conventional release oral tablet (clinical drug) | est un(e) (attribut) | Pyrimethamine-containing product in oral dose form | false | Inferred relationship | Some | ||
| Product containing precisely dapsone 100 milligram and pyrimethamine 12.5 milligram/1 each conventional release oral tablet (clinical drug) | a pour principe actif (attribut) | Dapsone (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely dapsone 100 milligram and pyrimethamine 12.5 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Dapsone (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely dapsone 100 milligram and pyrimethamine 12.5 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value (attribute) | 100 | false | Inferred relationship | Some | 1 | |
| Product containing precisely dapsone 100 milligram and pyrimethamine 12.5 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | milligram (qualifier value) | true | Inferred relationship | Some | 1 | |
| Product containing precisely dapsone 100 milligram and pyrimethamine 12.5 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator value | un | false | Inferred relationship | Some | 1 | |
| Product containing precisely dapsone 100 milligram and pyrimethamine 12.5 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Product containing precisely dapsone 100 milligram and pyrimethamine 12.5 milligram/1 each conventional release oral tablet (clinical drug) | a pour principe actif (attribut) | Pyrimethamine (substance) | false | Inferred relationship | Some | 2 | |
| Product containing precisely dapsone 100 milligram and pyrimethamine 12.5 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Pyrimethamine (substance) | false | Inferred relationship | Some | 2 | |
| Product containing precisely dapsone 100 milligram and pyrimethamine 12.5 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value (attribute) | 12.5 (qualifier value) | false | Inferred relationship | Some | 2 | |
| Product containing precisely dapsone 100 milligram and pyrimethamine 12.5 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | milligram (qualifier value) | true | Inferred relationship | Some | 2 | |
| Product containing precisely dapsone 100 milligram and pyrimethamine 12.5 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator value | un | false | Inferred relationship | Some | 2 | |
| Product containing precisely dapsone 100 milligram and pyrimethamine 12.5 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 2 | |
| Product containing precisely dapsone 100 milligram and pyrimethamine 12.5 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Pyrimethamine (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely dapsone 100 milligram and pyrimethamine 12.5 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value (attribute) | 12.5 (qualifier value) | false | Inferred relationship | Some | 1 | |
| Product containing precisely dapsone 100 milligram and pyrimethamine 12.5 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Dapsone (substance) | true | Inferred relationship | Some | 2 | |
| Product containing precisely dapsone 100 milligram and pyrimethamine 12.5 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value (attribute) | 100 | false | Inferred relationship | Some | 2 | |
| Product containing precisely dapsone 100 milligram and pyrimethamine 12.5 milligram/1 each conventional release oral tablet (clinical drug) | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some | ||
| Product containing precisely dapsone 100 milligram and pyrimethamine 12.5 milligram/1 each conventional release oral tablet (clinical drug) | est un(e) (attribut) | Dapsone- and pyrimethamine-containing product in oral dose form | false | Inferred relationship | Some | ||
| Product containing precisely dapsone 100 milligram and pyrimethamine 12.5 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Pyrimethamine (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely dapsone 100 milligram and pyrimethamine 12.5 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Dapsone (substance) | true | Inferred relationship | Some | 2 | |
| Product containing precisely dapsone 100 milligram and pyrimethamine 12.5 milligram/1 each conventional release oral tablet (clinical drug) | Count of base of active ingredient | deux | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR